The purpose of this randomized, parallel-group, single-blinded, single center, Phase II study is to collect data to compare the comfort and patient satisfaction of a hip injection delivered via the Navigator compared to a standard needle injection. In addition, delivery preparation will be compared between a Navigator injection and a standard hip injection. The data collected from this pilot study will serve as the basis to design a larger multi-center study.

Read more: http://www.clinicaltrials.gov/ct2/show/NCT02066844?cond=%22Arthritis%22&lup_s=01/29/2014&lup_d=30